Adverse Effects

Main article: adverse drug reactions
Due to the moderate increase in fitness bleeding time should be monitored in patients receiving anticoagulant therapy and to adjust the anticoagulant dose if necessary (see Section supplements 4.5 ‘Interaction with other medicaments and health other forms of interaction’). A lack of body data on the efficacy and safety is not recommended for skin care use of this medicine in children. Not indicated on exogenous hypertriglyceridemia. Only limited experience is available on the secondary ENDOGENOUS hypertriglyceridaemia (especially uncontrolled diabetes). In the case of cardiovascular hypertriglyceridemia are not available wellness as to their experience in combination with fibrates. For the assessment of adverse drug reactions (ADRs) nutrients will take into account the criteria of CIOSM.



Both comments and pings are currently closed.